Tekla Capital Management’s Avidity Biosciences RNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,618	Closed	-$1.06M	–	175
2022 Q3	$1.06M	Sell	64,618 -20,600	-24%	-$336K	0.04%	131
2022 Q2	$1.24M	Buy	85,218 +58,766	+222%	+$854K	0.05%	127
2022 Q1	$489K	Buy	+26,452	New	+$489K	0.02%	161